US › Healthcare

Mangoceuticals, Inc. Common Stock (MGRX)

US · Healthcare · Health Information Services

$0.45-1.64%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$68,757

Revenue YoY

-59.1%

Net profit

$-1.3M

EPS

$-0.09

Net margin

-1,909.1%

Key statistics

Market cap

$9.1M

Forward P/E

0.0

P/B

0.71

Book value

$0.69

EPS (TTM)

$-1.04

52-week high

$2.75

52-week low

$0.16

50-day MA

$0.44

200-day MA

$0.51

Beta

2.05

Shareholding

Insiders

7.99%

Institutions

5.62%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	1.57%
Geode Capital Management, LLC	0.90%
Ikarian Capital, LLC	0.64%
Vanguard Capital Management, LLC	0.57%
Jane Street Group LLC	0.34%
Virtu Financial LLC	0.28%
Vanguard Fiduciary Trust Co	0.27%
BOOTHBAY FUND MANAGEMENT, LLC	0.18%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Mangoceuticals, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.